MOBILENGINE LTD

Financial Health Assessment: MOBILENGINE LTD

Here is a comprehensive diagnostic evaluation of MOBILENGINE LTD's financial health based on the latest filed accounts and historical data.

1. Financial Health Score: A-

Explanation: The company exhibits robust financial health, evidenced by a consistent, multi-year upward trajectory in net assets and strong working capital. The balance sheet is well-capitalized and free from the symptoms of distress common to micro-entity software firms. The score is an A- rather than a perfect A due to the lack of detailed profit and loss visibility (a legal benefit of their filing status) and an unusual operational profile (zero employees despite a £2.8M asset base).

2. Key Vital Signs

• Net Assets (Shareholders' Funds): £1,995,312
  • Interpretation: This is the core measure of the company's net worth. It has grown steadily from £686,465 in 2019 to nearly £2M in 2025. This steady heartbeat of retained earnings indicates the business is consistently profitable and retaining cash internally rather than distributing it.
• Working Capital (Net Current Assets): £577,749
  • Interpretation: The difference between current assets (£936,930) and short-term liabilities (£359,181). This indicates a very healthy "immune system" against short-term cash flow shocks. The company has more than enough liquid resources to cover its immediate obligations.
• Fixed Assets: £1,865,897
  • Interpretation: Represents 66% of total assets. For a software development company, this likely consists of significant intellectual property (IP), software development costs, or long-term investments.
• Long-Term Liabilities: £448,334
  • Interpretation: Debts falling due after one year. This is comfortably structured and represents a manageable load against the company's £2.8M total asset base.
• Average Employees: 0
  • Interpretation: An anomaly for a company of this size. It suggests the company relies entirely on contractor labor, outsourced development, or remunerates its directors via dividends rather than PAYE salaries.

3. Diagnosis

Symptoms Analysis: The financial data reveals a business in excellent physiological condition. The year-on-year growth in shareholders' funds acts as a clear sign of commercial vitality. The company has successfully transitioned from a sub-£1M net asset valuation in 2019 to a nearly £2M valuation in 2025, pointing to a highly successful and scalable business model.

There is one minor symptom to monitor: short-term creditors jumped from £126,133 in 2024 to £359,181 in 2025. While current assets easily cover this, a sudden increase in trade payables can sometimes indicate stretched supplier terms or a temporary cash flow tightness. However, given the parallel increase in current assets, this appears to be a natural byproduct of business growth rather than a symptom of distress.

Overall Condition: The company is highly solvent, asset-rich, and accumulating wealth at a strong pace. It is financially stable with no immediate threats to its longevity.

4. Recommendations

• Monitor Short-Term Creditor Health: While working capital is strong, keep a close eye on the £359,181 owed within one year. Ensure supplier terms are managed actively so this does not become a chronic issue that damages commercial relationships.
• Asset Utilization Review: With nearly £1.9M tied up in fixed assets and zero employees, conduct a regular review to ensure these assets (likely IP or investments) are actively generating yield or supporting revenue generation. Capital tied up in non-productive assets is like stagnant blood flow—it needs to circulate to drive growth.
• Evaluate Filing Status: The company legally qualifies as a micro-entity and files filleted accounts, meaning no Profit & Loss statement is public. If the company intends to seek external investment, large contracts, or credit facilities in the future, consider voluntarily filing a full P&L to provide external parties with a transparent view of your operational profitability.